Article
TMBocelot: an omnibus statistical control model optimizing the TMB thresholds with systematic measurement errors.
Frontiers in immunology - 1 Jan 2024
Lai Xin, Wang Shaoliang, Zhang Xuanping, Zhu Xiaoyan, Liu Yuqian, Chang Zhili, Wang Xiaonan, Shao Yang, Wang Jiayin, Wang Yixuan
Abstract excerpt
Tumor mutation burden (TMB), defined as the number of somatic mutations of tumor DNA, is a well-recognized immunotherapy biomarker endorsed by regulatory agencies and pivotal in stratifying patients for clinical decision-making. However, measurement errors can compromise the accuracy of TMB assessments and the reliability of clinical outcomes, introducing bias into statistical inferences and adversely affecting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
